|
RAP2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
2.263200E-03 |
| Normal-vs-Stage3 |
9.72980000000234E-05 |
| Normal-vs-Stage4 |
1.702200E-02 |
| Stage1-vs-Stage2 |
3.674000E-02 |
| Stage1-vs-Stage3 |
4.39740000000022E-05 |
| Stage1-vs-Stage4 |
1.80420001161252E-09 |
| Stage2-vs-Stage3 |
4.788600E-01 |
| Stage2-vs-Stage4 |
9.486000E-02 |
| Stage3-vs-Stage4 |
1.419610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
4.452200E-02 |
| Normal-vs-Asian |
5.414500E-02 |
| Caucasian-vs-AfricanAmerican |
8.424400E-04 |
| Caucasian-vs-Asian |
2.349000E-01 |
| AfricanAmerican-vs-Asian |
1.216960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18192131029582E-12 |
| Normal-vs-Female |
1.21569421196455E-12 |
| Male-vs-Female |
3.648200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.539400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.78010947596385E-12 |
| Normal-vs-Age(61-80Yrs) |
2.86504153734768E-12 |
| Normal-vs-Age(81-100Yrs) |
6.541600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.795000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.528200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.786000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.532200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.920240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.459600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.619380E-03 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.6411000336447E-09 |
| Normal-vs-Grade 4 |
9.218500E-02 |
| Grade 1-vs-Grade 2 |
5.495000E-01 |
| Grade 1-vs-Grade 3 |
2.083500E-02 |
| Grade 1-vs-Grade 4 |
2.173000E-04 |
| Grade 2-vs-Grade 3 |
1.616680E-04 |
| Grade 2-vs-Grade 4 |
3.35439998000453E-09 |
| Grade 3-vs-Grade 4 |
3.841500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.87980000000621E-05 |
| ccA subtype-vs-ccB subtype |
3.42880002168755E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.6183945556777E-11 |
| Normal-vs-N1 |
2.272400E-01 |
| N0-vs-N1 |
3.419600E-01 |
|
|
